203 related articles for article (PubMed ID: 19857109)
21. Successful Treatment with Infliximab for Refractory Uveitis in a Hemodialysis Patient with Behçet's Disease and a Review of the Literature for Infliximab Use in Patients on Hemodialysis.
Kurata I; Tsuboi H; Takahashi H; Abe S; Ebe H; Hagiwara S; Umeda N; Kondo Y; Ogishima H; Suzuki T; Matsumoto I; Hoshi S; Oshika T; Sumida T
Intern Med; 2015; 54(12):1553-7. PubMed ID: 26073249
[TBL] [Abstract][Full Text] [Related]
22. Phacoemulsification cataract extraction and intraocular lens implantation in patients with uveitis.
Kawaguchi T; Mochizuki M; Miyata K; Miyata N
J Cataract Refract Surg; 2007 Feb; 33(2):305-9. PubMed ID: 17276275
[TBL] [Abstract][Full Text] [Related]
23. Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.
Guzelant G; Ucar D; Esatoglu SN; Hatemi G; Ozyazgan Y; Yurdakul S; Seyahi E; Yazici H; Hamuryudan V
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):86-89. PubMed ID: 29148418
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of infliximab therapy in active behcet's uveitis: an open-label trial.
Al-Rayes H; Al-Swailem R; Al-Balawi M; Al-Dohayan N; Al-Zaidi S; Tariq M
Rheumatol Int; 2008 Nov; 29(1):53-7. PubMed ID: 18496694
[TBL] [Abstract][Full Text] [Related]
25. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
Interlandi E; Leccese P; Olivieri I; Latanza L
Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S58-62. PubMed ID: 25005224
[TBL] [Abstract][Full Text] [Related]
26. Regression of optic disc neovascularization in patients with Behçet's uveoretinitis after infliximab therapy.
Kawaguchi T; Sugita S; Yamada Y; Miyanaga M; Mochizuki M
J Ocul Pharmacol Ther; 2010 Dec; 26(6):627-30. PubMed ID: 21043804
[TBL] [Abstract][Full Text] [Related]
27. Adalimumab for sight-threatening uveitis in Behçet's disease.
Mushtaq B; Saeed T; Situnayake RD; Murray PI
Eye (Lond); 2007 Jun; 21(6):824-5. PubMed ID: 16601736
[TBL] [Abstract][Full Text] [Related]
28. [Clinical results after cataract surgery in patients with Behçet's disease].
Saygili O; Szurman P; Gieselmann S; Deuter C; Spitzer MS; Thaler S; Bartz-Schmidt KU; Yoeruek E
Klin Monbl Augenheilkd; 2011 Oct; 228(10):900-4. PubMed ID: 21656461
[TBL] [Abstract][Full Text] [Related]
29. Cataract extraction comparative study of ocular Behçet's disease and idiopathic uveitis.
Ciftci OU; Ozdemir O
Ophthalmologica; 1995; 209(5):270-4. PubMed ID: 8570151
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
Zlatanović G; Jovanović S; Veselinović D; Zivković M
Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
[TBL] [Abstract][Full Text] [Related]
31. Induction of regulatory T cells by infliximab in Behcet's disease.
Sugita S; Yamada Y; Kaneko S; Horie S; Mochizuki M
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):476-84. PubMed ID: 20861484
[TBL] [Abstract][Full Text] [Related]
32. Clinical experience with adalimumab in the treatment of ocular Behçet disease.
Bawazeer A; Raffa LH; Nizamuddin SH
Ocul Immunol Inflamm; 2010 Jun; 18(3):226-32. PubMed ID: 20482404
[TBL] [Abstract][Full Text] [Related]
33. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
Tabbara KF; Al-Hemidan AI
Am J Ophthalmol; 2008 Dec; 146(6):845-50.e1. PubMed ID: 18929351
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of the eye function and complications after removal of complicated cataract due to uveitis and senile cataract.
Jurowski P; Goś R; Kaszuba-Bartkowiak K; Zeman-Miecznik A
Klin Oczna; 2005; 107(7-9):421-5. PubMed ID: 16416988
[TBL] [Abstract][Full Text] [Related]
35. Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment.
Yamada Y; Sugita S; Tanaka H; Kamoi K; Takase H; Mochizuki M
Br J Ophthalmol; 2011 Feb; 95(2):205-8. PubMed ID: 20542984
[TBL] [Abstract][Full Text] [Related]
36. Postoperative outcomes after implantation of intraocular lenses in eyes with cataract and uveitis.
Mandić Z; Petric I; Bencić G; Vatavuk Z; Bojić L
Coll Antropol; 2005; 29 Suppl 1():9-12. PubMed ID: 16193667
[TBL] [Abstract][Full Text] [Related]
37. Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab).
Benitez-del-Castillo JM; Martinez-de-la-Casa JM; Pato-Cour E; Méndez-Fernández R; López-Abad C; Matilla M; Garcia-Sanchez J
Eye (Lond); 2005 Aug; 19(8):841-5. PubMed ID: 15389273
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
[TBL] [Abstract][Full Text] [Related]
39. Infliximab in refractory uveitis due to Behçet's disease.
Wechsler B; Sablé-Fourtassou R; Bodaghi B; Huong DL; Cassoux N; Badelon I; Fain O; LeHoang P; Piette JC
Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
[TBL] [Abstract][Full Text] [Related]
40. [Infliximab treatment trial in a patient with neuro-Behçet's disease unresponsive to other treatments].
Kadowaki S; Matsuda N; Moriya A; Ebitani M; Yoshihara A; Nakamura K; Mochizuki H; Ugawa Y
Rinsho Shinkeigaku; 2011 Apr; 51(4):261-6. PubMed ID: 21595295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
